GMO U.S. Equity Allocation Fund

Scorecard
3 / 5 Stars
Lipper
3 2 5 5 2
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
A+ (Buy)